Joyce Wall
Primary Care · Hamden, CTNPI 1457949000
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 26.8% of the total. 2025 is the largest year on record at $2,453, more than ten times the $46 reported in 2022. Among primary care clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $20.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Otsuka America Pharmaceutical, Inc.$683
- GSK$616
- AbbVie$550
- Novo Nordisk$365
- Lilly USA, LLC$219
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,924100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 62 | $1,320 |
| Otsuka America Pharmaceutical, Inc. | 31 | $683 |
| GSK | 31 | $616 |
| AbbVie | 31 | $550 |
| Novo Nordisk | 17 | $365 |
| Lilly USA, LLC | 11 | $219 |
| Inspire Medical Systems, Inc. | 7 | $184 |
| Axsome Therapeutics, Inc. | 7 | $180 |
| Exact Sciences | 8 | $173 |
| Amgen | 5 | $123 |
| Merck | 5 | $96 |
| Lundbeck LLC | 4 | $90 |
| Johnson & Johnson | 3 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Janssen Scientific Affairs, LLC | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Philips North America LLC | 1 | $20 |
| Pfizer | 1 | $19 |
How this compares
$4,924 in reported general payments places this provider in the 95th percentile of 111 primary care providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 36 | $310 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $305 |
| Escitalopram Oxalate | 13 | $176 |
| Rosuvastatin Calcium | 15 | $166 |
| Atorvastatin Calcium | 19 | $161 |
| Amlodipine Besylate | 36 | $118 |
| Fluticasone Propionate | 11 | $49 |
| Azithromycin | 14 | $48 |
| Lisinopril | 13 | $47 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other primary care in Hamden
- Rose AntoineHamden$449
- Kelly NolinEnfield$16K
- Deanna BallardDanbury$7K
- Jacqueline VelezBridgeport$7K
- Catherine KrenickyPawcatuck$5K
- Christopher AndersonGroton$5K
- Carolyn BrownMiddlebury$4K
- Ivanna TsykhulyakWaterbury$3K
- Rosaleen GalvinBridgeport$3K
- Erica SeebeckWilton$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.